Cargando…

The 10-year outcomes of the ASR XL Acetabular System: a single-center experience from China

BACKGROUND: The revision rate of articular surface replacement (ASR) implants continues to rise in China because of metal debris. However, there are few reports on the clinical results of ASR implants with prolonged follow-up time in China. This study investigated the clinical outcomes and the risk...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Guojun, Ran, Jisheng, Chen, Weiping, Xiong, Yan, Bao, Jiapeng, Wu, Lidong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6534829/
https://www.ncbi.nlm.nih.gov/pubmed/31126346
http://dx.doi.org/10.1186/s13018-019-1173-2
_version_ 1783421486201044992
author Jin, Guojun
Ran, Jisheng
Chen, Weiping
Xiong, Yan
Bao, Jiapeng
Wu, Lidong
author_facet Jin, Guojun
Ran, Jisheng
Chen, Weiping
Xiong, Yan
Bao, Jiapeng
Wu, Lidong
author_sort Jin, Guojun
collection PubMed
description BACKGROUND: The revision rate of articular surface replacement (ASR) implants continues to rise in China because of metal debris. However, there are few reports on the clinical results of ASR implants with prolonged follow-up time in China. This study investigated the clinical outcomes and the risk factors of revision surgery in patients with ASR implants. METHODS: In total, 74 patients (74 hips) who underwent primary total hip arthroplasty (THA) with ASR implants over the past 4 to 10 years were retrospectively analyzed. Relevant clinical, radiographic, and biochemical data were examined. RESULTS: The average follow-up time was 88.46 (range 23–114) months, and the ASR implants of 18 hips (24.3%) were revised. Patients who received revision surgery had worse joint function with significantly lower Harris Hip Score and Western Ontario and McMaster Universities index than non-revision patients (61.11 ± 6.68 vs 85.30 ± 9.16, p < 0.001; 61.00 ± 3.83 vs 79.04 ± 14.49, p < 0.001; respectively). Higher acetabular abduction angle and serum Co and Cr concentration were significantly relevant to worse joint function as measured by HSS (p = 0.018, 0.009, 0.043, respectively). ROC curve analysis was applied to categorize the optimal cutoff values of acetabular abduction angle and serum Cr and Co concentration for revision surgery, which were settled as 47.80°, 98.44 μg/L, and 6.95 μg/L, respectively. Overall survival of the prostheses with high acetabular abduction angle (> 47.80°, HR = 70.145, 95% CI 1.558–3158.213, p = 0.029), high serum Cr concentration (98.44 μg/L, HR = 58.956, 95% CI 1.294–2685.203, p = 0.036), and high serum Co concentration (> 6.95 μg/L, HR = 179.511, 95% CI 2.360–13656.941, p = 0.019) decreased significantly than the lower groups. CONCLUSIONS: Evaluation of the DePuy ASR XL articulation demonstrated increased rates of revision following a longer follow-up period. High acetabular abduction angle and serum Cr and Co concentration correlated with worse clinical outcomes and high revision rate. Therefore, we advocate that patients with DePuy ASR XL implants be followed up more closely than those with other implants, especially with high acetabular abduction angle and serum Cr or Co concentration.
format Online
Article
Text
id pubmed-6534829
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-65348292019-05-28 The 10-year outcomes of the ASR XL Acetabular System: a single-center experience from China Jin, Guojun Ran, Jisheng Chen, Weiping Xiong, Yan Bao, Jiapeng Wu, Lidong J Orthop Surg Res Research Article BACKGROUND: The revision rate of articular surface replacement (ASR) implants continues to rise in China because of metal debris. However, there are few reports on the clinical results of ASR implants with prolonged follow-up time in China. This study investigated the clinical outcomes and the risk factors of revision surgery in patients with ASR implants. METHODS: In total, 74 patients (74 hips) who underwent primary total hip arthroplasty (THA) with ASR implants over the past 4 to 10 years were retrospectively analyzed. Relevant clinical, radiographic, and biochemical data were examined. RESULTS: The average follow-up time was 88.46 (range 23–114) months, and the ASR implants of 18 hips (24.3%) were revised. Patients who received revision surgery had worse joint function with significantly lower Harris Hip Score and Western Ontario and McMaster Universities index than non-revision patients (61.11 ± 6.68 vs 85.30 ± 9.16, p < 0.001; 61.00 ± 3.83 vs 79.04 ± 14.49, p < 0.001; respectively). Higher acetabular abduction angle and serum Co and Cr concentration were significantly relevant to worse joint function as measured by HSS (p = 0.018, 0.009, 0.043, respectively). ROC curve analysis was applied to categorize the optimal cutoff values of acetabular abduction angle and serum Cr and Co concentration for revision surgery, which were settled as 47.80°, 98.44 μg/L, and 6.95 μg/L, respectively. Overall survival of the prostheses with high acetabular abduction angle (> 47.80°, HR = 70.145, 95% CI 1.558–3158.213, p = 0.029), high serum Cr concentration (98.44 μg/L, HR = 58.956, 95% CI 1.294–2685.203, p = 0.036), and high serum Co concentration (> 6.95 μg/L, HR = 179.511, 95% CI 2.360–13656.941, p = 0.019) decreased significantly than the lower groups. CONCLUSIONS: Evaluation of the DePuy ASR XL articulation demonstrated increased rates of revision following a longer follow-up period. High acetabular abduction angle and serum Cr and Co concentration correlated with worse clinical outcomes and high revision rate. Therefore, we advocate that patients with DePuy ASR XL implants be followed up more closely than those with other implants, especially with high acetabular abduction angle and serum Cr or Co concentration. BioMed Central 2019-05-24 /pmc/articles/PMC6534829/ /pubmed/31126346 http://dx.doi.org/10.1186/s13018-019-1173-2 Text en © The Author(s). 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Jin, Guojun
Ran, Jisheng
Chen, Weiping
Xiong, Yan
Bao, Jiapeng
Wu, Lidong
The 10-year outcomes of the ASR XL Acetabular System: a single-center experience from China
title The 10-year outcomes of the ASR XL Acetabular System: a single-center experience from China
title_full The 10-year outcomes of the ASR XL Acetabular System: a single-center experience from China
title_fullStr The 10-year outcomes of the ASR XL Acetabular System: a single-center experience from China
title_full_unstemmed The 10-year outcomes of the ASR XL Acetabular System: a single-center experience from China
title_short The 10-year outcomes of the ASR XL Acetabular System: a single-center experience from China
title_sort 10-year outcomes of the asr xl acetabular system: a single-center experience from china
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6534829/
https://www.ncbi.nlm.nih.gov/pubmed/31126346
http://dx.doi.org/10.1186/s13018-019-1173-2
work_keys_str_mv AT jinguojun the10yearoutcomesoftheasrxlacetabularsystemasinglecenterexperiencefromchina
AT ranjisheng the10yearoutcomesoftheasrxlacetabularsystemasinglecenterexperiencefromchina
AT chenweiping the10yearoutcomesoftheasrxlacetabularsystemasinglecenterexperiencefromchina
AT xiongyan the10yearoutcomesoftheasrxlacetabularsystemasinglecenterexperiencefromchina
AT baojiapeng the10yearoutcomesoftheasrxlacetabularsystemasinglecenterexperiencefromchina
AT wulidong the10yearoutcomesoftheasrxlacetabularsystemasinglecenterexperiencefromchina
AT jinguojun 10yearoutcomesoftheasrxlacetabularsystemasinglecenterexperiencefromchina
AT ranjisheng 10yearoutcomesoftheasrxlacetabularsystemasinglecenterexperiencefromchina
AT chenweiping 10yearoutcomesoftheasrxlacetabularsystemasinglecenterexperiencefromchina
AT xiongyan 10yearoutcomesoftheasrxlacetabularsystemasinglecenterexperiencefromchina
AT baojiapeng 10yearoutcomesoftheasrxlacetabularsystemasinglecenterexperiencefromchina
AT wulidong 10yearoutcomesoftheasrxlacetabularsystemasinglecenterexperiencefromchina